News
12 Health Care Stocks Moving In Friday's After-Market Session
5 Apr 24
Movers
JMP Securities Reiterates Market Outperform on Vor Biopharma, Maintains $12 Price Target
22 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Stifel Maintains Buy on Vor Biopharma, Lowers Price Target to $12
21 Mar 24
News, Price Target, Analyst Ratings
Wedbush Reiterates Outperform on Vor Biopharma, Maintains $11 Price Target
21 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Oppenheimer Reiterates Outperform on Vor Biopharma, Lowers Price Target to $15
21 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Vor Biopharma: Q4 Earnings Insights
20 Mar 24
Earnings
Vor Biopharma Q4 2023 GAAP EPS $(0.39) Beats $(0.51) Estimate
20 Mar 24
Earnings, Earnings Beats, News
Press releases
Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
20 Mar 24
Earnings, Press Releases
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
5 Mar 24
Press Releases
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2 Feb 24
Press Releases